pid,type,title,authors,mentors,source_title,published_date,url,doi,isbn,issn,eissn
pharma:2873,thesis,"Provođenje mjera minimizacije rizika primjene fluoropirimidina u Republici Hrvatskoj","Koren, Sara",,,,,,,,
mef:6693,"journal article","Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy","Božina, Nada; Šušak Sporiš, Ivana; Klarica Domjanović, Iva; Ganoci, Lana; Šimičević, Livija; Lovrić, Mila; Čolak Romić, Zrinka; Petelin Gadže, Željka; Trkulja, Vladimir",,,,,,,,
pharma:2819,thesis,"Antinociceptivni učinak botulinum toksina tipa A u animalnom modelu boli uzrokovane formalinom","Mustapić, Matej",,,,,,,,
mef:7204,"journal article","Risk Factors for Rivaroxaban-Related Bleeding Events - Possible Role of Pharmacogenetics: Case Series","Šimičević, Livija; Slišković, Ana Marija; Vrkić Kirhmajer, Majda; Ganoci, Lana; Holik, Hrvoje; Palić, Jozefina; Samardžić, Jure; Božina, Tamara",,,,,,,,
mef:6511,"journal article","ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population","Božina, Tamara; Ganoci, Lana; Karačić, Ena; Šimičević, Livija; Vrkić-Kirhmajer, Majda; Klarica-Domjanović, Iva; Križ, Tena; Sertić, Zrinka; Božina, Nada",,,,,,,,
pharma:2523,thesis,"Učestalost polimorfizama CYP3A4*1B, CYP3A4*22 i CYP3A5*3 u hrvatskoj populaciji","Petreković, Sandra",,,,,,,,
pharma:2636,thesis,"Genotipizacija CYP2C9 u kliničkoj praksi","Krsmanović, Dora",,,,,,,,
pharma:2228,thesis,"Polimorfizmi gena ABCG2 i SLCO1B1 kao rizični čimbenici terapije statinima (ABCG2 and SLCO1B1 gene polymorphisms as risk factors to statin therapy","Karačić, Ena",,,,,,,,
mef:4062,"journal article","ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone","Ganoci, Lana; Trkulja, Vladimir; Živković, Maja; Božina, Tamara; Šagud, Marina; Lovrić, Mila; Božina, Nada",,,,,,,,
mef:2550,"journal article","Use of pharmacogenomics in elderly patients treated for cardiovascular diseases","Božina, Nada; Vrkić Kirhmajer, Majda; Šimičević, Livija; Ganoci, Lana; Mirošević Skvrce, Nikica; Klarica Domjanović, Iva; Merčep, Iveta",,,,,,,,
mef:6284,dissertation,"Utjecaj farmakogenetičkih varijacija CYP2D6 i ABCB1 na liječenje pripravkom risperidona s produljenim oslobađanjem ","Ganoci, Lana",,,,,,,,
mef:2710,"journal article","The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study","Živković, Maja; Mihaljević-Peleš, Alma; Muck-Šeler, Dorotea; Šagud, Marina; Ganoci, Lana; Vlatković, Suzana; Nikolac Perković, Matea; Tudor, Lucija; Božina, Nada; Pivac, Nela",,,,,,,,
medri:5208,"journal article","CYP2D6 *6/*6 genotype and drug interactions as cause of haloperidol induced extrapyramidal symptoms","Šimić, Iveta; Potočnjak, Ines; Kraljičković, Iva; Stanić Benić, Mirjana; Čegec, Ivana; Juričić Nahal, Danica; Ganoci, Lana; Božina, Nada",,,,,,,,